- Home
- TAC
as 02-21-2025 4:00pm EST
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, hydro, wind & solar, Energy Marketing, gas, energy transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
| Founded: | 1909 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.0B | IPO Year: | N/A |
| Target Price: | $19.50 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.41 | EPS Growth: | -74.85 |
| 52 Week Low/High: | $5.94 - $14.64 | Next Earning Date: | 02-20-2025 |
| Revenue: | $1,977,287,259 | Revenue Growth: | -15.20% |
| Revenue Growth (this year): | -13.56% | Revenue Growth (next year): | -12.45% |
Latest TransAlta Corporation News
TAC Breaking Stock News: Dive into TAC Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
TransAlta Full Year 2024 Earnings: EPS Misses Expectations
GuruFocus.com
a day ago
TransAlta Corp (TAC) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ...
MT Newswires
2 days ago
TransAlta Fourth-Quarter Loss Narrows on Revenue Gain; Hikes Dividend 8%, Issues 2025 Guidance
MT Newswires
2 days ago
TransAlta Q4 Net Loss Narrows, Revenue Rises
Associated Press Finance
2 days ago
TransAlta: Q4 Earnings Snapshot
GlobeNewswire
2 days ago
TransAlta Reports Strong 2024 Results, Announces Dividend Increase and 2025 Annual Guidance
TipRanks
3 days ago
Capital Power upgraded to Outperformer at CIBC following valuation reset
TipRanks
3 days ago
CIBC upgrades TransAlta to Outperformer as valuation reset creates better entry
Compare TAC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TAC TransAlta Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.